GlobeNewswire•12 days agoTScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateTCRX0.17%
Business Wire•Jul 21, 2026Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 for Patients With Friedreich’s Ataxia